Trevi Therapeutics
TRVI
#7266
Rank
A$0.58 B
Marketcap
$6.52
Share price
0.25%
Change (1 day)
219.10%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$65.84 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$46.12 Million a decrease over its 2022 earnings that were of -A$45.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$65.84 Million42.78%
2023 -A$46.12 Million2.43%
2022 -A$45.02 Million-14.45%
2021 -A$52.63 Million1.36%
2020 -A$51.92 Million23.64%
2019 -A$41.99 Million27.54%
2018 -A$32.93 Million